Breast cancer is not a partisan issue — we need to work together to address it

To protect doctor patient preference in decision-making, we need to reduce cost and address barriers to breast cancer treatments, such as requiring that insurance companies and government programs eliminate the difference in cost structure between oral chemotherapy drugs and those that are given through IV. Other reforms should include precluding specialty drug tiers, preventing protocols that require step therapy (trying cheaper alternative drugs first to show they won’t work before moving on to the next drug, which ultimately wastes time that can be critical for a cancer patient), and preventing switching of medications for non-medical reasons.

Read full letter here